6-Gingerol Protects against Nutritional Steatohepatitis by Regulating Key Genes Related to Inflammation and Lipid Metabolism
暂无分享,去创建一个
I-Min Liu | Thing-Fong Tzeng | Shorong-Shii Liou | Chia Ju Chang | T. Tzeng | S. Liou | I. Liu | C. Chang
[1] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[2] F. Gonzalez,et al. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet. , 2014, Biochimica et biophysica acta.
[3] Jung-Chun Liao,et al. Analgesic and anti-inflammatory activities of [6]-gingerol. , 2005, Journal of ethnopharmacology.
[4] M. Sherman,et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. , 2008, Journal of hepatology.
[5] E. Zandi,et al. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. , 1997, Nature.
[6] W. Chang,et al. Inhibitory effects of phenolics on xanthine oxidase. , 1994, Anticancer research.
[7] S. Kersten,et al. Peroxisome proliferator-activated receptor α target genes , 2004, Cellular and Molecular Life Sciences CMLS.
[8] I. Leclercq,et al. Administration of the potent PPARα agonist, Wy‐14,643, reverses nutritional fibrosis and steatohepatitis in mice , 2004, Hepatology.
[9] A. Koteish,et al. Animal models of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.
[10] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[11] K. Tsuneyama,et al. Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. , 2012, The Journal of toxicological sciences.
[12] M. Goldring,et al. NF-kappaB signaling: multiple angles to target OA. , 2010, Current drug targets.
[13] H. Kwan,et al. Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells , 2013, European Journal of Nutrition.
[14] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[15] D. Lawlor,et al. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. , 2007, Gastroenterology.
[16] K. Ogawa,et al. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. , 2013, International journal of clinical and experimental pathology.
[17] M. Nyirenda,et al. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis , 2010, American journal of physiology. Endocrinology and metabolism.
[18] G. Farrell,et al. Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.
[19] Michael Müller,et al. Peroxisome Proliferator-Activated Receptor Alpha Target Genes , 2010, PPAR research.
[20] M. Hesselink,et al. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids , 2001, Histochemistry and Cell Biology.
[21] A. Lombardi,et al. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[22] R. Harmon,et al. Inflammation in nonalcoholic steatohepatitis , 2011, Expert review of gastroenterology & hepatology.
[23] C. Teng,et al. Antiplatelet Effect of Gingerol Isolated from Zingiber officinale , 1995, The Journal of pharmacy and pharmacology.
[24] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.
[25] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[26] Xiao-Hong Li,et al. Attenuation of Proinflammatory Responses by S-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells , 2013, Evidence-based complementary and alternative medicine : eCAM.
[27] M. Duvnjak,et al. Pathogenesis and management issues for non-alcoholic fatty liver disease. , 2007, World journal of gastroenterology.
[28] J. Corton,et al. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. , 2000, Annual review of pharmacology and toxicology.
[29] Y. Surh,et al. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo , 2007, Free radical research.
[30] F. Gonzalez,et al. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. , 2011, The Journal of nutrition.
[31] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[32] J. Tieppo,et al. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. , 2011, Arquivos de gastroenterologia.
[33] N. Lalwani,et al. Induction of hepatic peroxisome proliferation in nonrodent species, including primates. , 1984, The American journal of pathology.
[34] Jianghua Chen,et al. Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report , 2009, European Journal of Clinical Pharmacology.
[35] A. Casquero,et al. Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver , 2009, Lipids in Health and Disease.
[36] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[37] D. Vance,et al. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. , 1995, Biochimica et biophysica acta.
[38] Robert V Farese,et al. Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice* , 2004, Journal of Biological Chemistry.
[39] Nilendra Singh,et al. Anti-hyperglycaemic, lipid lowering and anti-oxidant properties of (6)-gingerol in db/db mice , 2009 .
[40] M. Goldring,et al. NF-kappaB signaling: multiple angles to target OA. , 2010, Current drug targets.